Ticker

Even before the purchase, Vireo Growth had a strong third quarter. The Hawthorne subsidiary was seen as a drag on Scotts Miracle-Gro's margins.

Planned share-based transaction is expected to be completed during the first fiscal quarter of 2026 Vireo plans to appoint Chris Hagedorn to its Board of Directors MINNEAPOLIS, Jan. 28, 2026 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it has entered into a nonbinding Memorandum of Understanding (“MOU”) with The Scotts Miracle-Gro Company…

MINNEAPOLIS, Dec. 19, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo” or the “Company”) today announced that it plans to acquire additional outstanding senior secured convertible notes (the “Notes”) of Medicine Man Technologies Inc. (dba “Schwazze”) from third-party noteholders. Total outstanding principal plus accrued interest of the acquired Notes is approximately $2.6…

Acquired assets further optimize Vireo's operating footprint in Colorado with addition of 17 dispensaries Transaction expands Vireo's leadership position in the Colorado retail market with 41 total dispensaries Parties also enter into Management Services Agreement through closing which is expected in 1H'26 MINNEAPOLIS, Dec. 16, 2025 (GLOBE NEWSWIRE) -- Vireo Growth Inc. (“Vireo”) (CSE: VREO; OTCQX: VREOF) (“Vireo”…